Reduction of prostate cancer incidence by naftopidil, an α<sub>1</sub>‐adrenoceptor antagonist and transforming growth factor‐β signaling inhibitor - Concepedia

Concepedia

Publication | Open Access

Reduction of prostate cancer incidence by naftopidil, an α<sub>1</sub>‐adrenoceptor antagonist and transforming growth factor‐β signaling inhibitor

DOI Full Paper Access

30

Citations

15

References

2013

Year

Daisuke Yamada, Hiroaki Nishimatsu, Shintaro Kumano, Yoshikazu Hirano, Motofumi Suzuki, Tetsuya Fujimura, Hiroshi Fukuhara, Yutaka Enomoto, Haruki Kume, Yukio Homma

International Journal of Urology

Abstract

Naftopidil seems to reduce prostate cancer incidence, possibly by inducing apoptosis, preferentially in cancer cells, and blocking transforming growth factor-β signaling.

References

	Year	Citations

Page 1